Binghamton, NY, United States of America

Kristine Hovancik


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 88(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Kristine Hovancik in Arthritis Treatment

Introduction

Kristine Hovancik is an accomplished inventor based in Binghamton, NY (US). She has made significant contributions to the field of medicine, particularly in the treatment of arthritis. Her innovative approach combines the use of phosphonates and NSAIDs to provide effective treatment options for patients suffering from this debilitating condition.

Latest Patents

Kristine Hovancik holds 1 patent for her invention titled "Methods for the treatment of arthritis using phosphonates and NSAIDS." This patent outlines a comprehensive treatment regimen that spans sixty days, incorporating both optional NSAID administration and a phosphonate administration regimen. This method aims to alleviate the symptoms of rheumatoid arthritis and osteoarthritis, offering hope to many patients.

Career Highlights

Hovancik is associated with The Procter & Gamble Company, where she has been able to apply her expertise in developing innovative solutions for health-related issues. Her work has not only contributed to the company's portfolio but has also advanced the understanding of arthritis treatment.

Collaborations

Throughout her career, Kristine has collaborated with notable colleagues, including Marion David Francis and Richard Allen Underwood. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Kristine Hovancik's contributions to arthritis treatment through her patented methods exemplify her dedication to improving patient care. Her work continues to inspire advancements in medical treatments and showcases the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…